A.K. Pharma

A.K. Pharma

Cancer

Tagrisso® (Osimertinib)

Osimertinib 40mg, 80mg Tablets — Third Generation EGFR Tyrosine Kinase Inhibitor for NSCLC

Tevimbra® (Tislelizumab)

Tislelizumab 100mg/10mL Injection — PD-1 Checkpoint Inhibitor for Esophageal and Gastric Cancers

Tibsovo® (Ivosidenib)

Ivosidenib 250mg Tablets — IDH1 Inhibitor for IDH1-Mutated Acute Myeloid Leukaemia, Myelodysplastic Syndromes and Previously Treated IDH1-Mutated Cholangiocarcinoma

Tishtha® (Nivolumab)

Nivolumab 40mg and 100mg Injection — PD-1 Checkpoint Inhibitor for Multiple Advanced Cancers

Trodelvy® (Sacituzumab Govitecan)

Sacituzumab Govitecan 180mg Injection — TROP-2 Targeted Antibody-Drug Conjugate for Triple-Negative Breast Cancer and HR-Positive HER2-Negative Breast Cancer

Truqap® (Capivasertib)

Capivasertib 200mg Tablets — AKT Inhibitor for Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Venclexta® (Venetoclax)

Venetoclax 10mg, 50mg, 100mg Tablets — BCL-2 Inhibitor for CLL, SLL and AML

Venclyxto

100mg

Yervoy

50mg/10mL

Zefotib 250mg Tab

1 X 10

Zelbaoraf® (Vemurafenib)

Vemurafenib 240mg Film-Coated Tablets — BRAF V600E Kinase Inhibitor for Unresectable or Metastatic BRAF V600E-Mutated Melanoma and BRAF V600E Mutation-Positive Erdheim-Chester Disease

Zelgor 250mg

120 Tab

Zoladex® (Goserelin)

Goserelin 3.6mg, 10.8mg Implant — GnRH Agonist for Hormone-Sensitive Prostate Cancer and Premenopausal Breast Cancer

No more Medicines to show